DrugDashboards

Market view

lidocaine hydrochloride anhydrous and dextrose monohydrate

4 marketed package NDCs · 2 active manufacturers

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately. It is in shortage right now.

What changed in the last 90 days

Every detected change for lidocaine hydrochloride anhydrous and dextrose monohydrate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Amide Local Anesthetic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Lidocaine hydrochloride anhydrous and dextrose monohydrate in shortage right now?
Yes. FDA currently lists Lidocaine hydrochloride anhydrous and dextrose monohydrate in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Lidocaine hydrochloride anhydrous and dextrose monohydrate?
2 companies have marketed Lidocaine hydrochloride anhydrous and dextrose monohydrate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.

Shortage reports for this molecule

  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-10)Oct 25, 2017
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .4 g/100 mL (NDC 0264-9594-20)Oct 25, 2017
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 5 g/100 mL; .8 g/100 mL (NDC 0264-9598-20)Oct 25, 2017

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.